Who Is Buying Northrop Grumman? Hedge Fund Activity in 2026

Northrop Grumman is the stealth technology leader of the defense industry — the company behind the B-21 Raider next-generation bomber, the James Webb Space Telescope, and critical components of America's nuclear deterrent triad. As geopolitical tensions drive renewed focus on advanced military capabilities, NOC sits at the intersection of virtually every major defense modernization program. The latest 13F filings reveal a perfectly balanced institutional tug-of-war with some fascinating new entrants.

Of the 18 major funds actively holding Northrop Grumman, the picture splits evenly: 6 buying, 6 selling, and 6 holding. But beneath this balanced surface, the quality of the buyers — including three brand-new positions — tells a more nuanced story.

Institutional Activity at a Glance

• Funds Buying: 6
• Funds Selling: 6
• Funds Holding: 6
• Active Funds Tracked: 18 of 35

A perfectly balanced 6-6-6 split might seem uninformative at first glance, but the composition matters enormously. When you look at who is initiating new positions versus who is trimming existing ones, the picture shifts meaningfully toward cautious optimism.

Who's Buying NOC?

The buying side features three entirely new positions — an unusually high number that signals fresh institutional interest:

Renaissance Technologies initiated a NEW $65.8 million position. Jim Simons' legendary quantitative fund opening a fresh position in Northrop Grumman is a powerful signal. Renaissance's algorithms process enormous datasets to identify statistical edges, and a $65.8 million new entry suggests their models see a favorable risk-reward setup. Renaissance doesn't make casual bets — every position is backed by rigorous quantitative analysis.

Bridgewater Associates initiated a NEW $4.5 million position. Ray Dalio's macro-driven fund entering NOC aligns with Bridgewater's thesis around rising geopolitical instability and the need for increased defense spending. While the position is relatively small for Bridgewater, new entries from the world's largest hedge fund often mark the beginning of a larger accumulation phase.

Baker Bros Advisors initiated a NEW $2.4 million position. While Baker Bros is primarily known as a healthcare specialist, their entry into a defense name suggests cross-sector analysis has identified an opportunity — possibly related to Northrop's growing role in military healthcare technology and biological defense systems.

Three additional funds also increased their existing positions, contributing to a buyer group that spans quantitative, macro, and specialist strategies.

Who's Selling NOC?

The selling side features meaningful reductions across several institutional styles:

Canyon Capital completely SOLD its entire position — the most dramatic move on either side. A full exit signals that Canyon's investment thesis has either played out or been invalidated. Canyon is known for event-driven and distressed investing, so their exit may reflect a view that the catalysts they originally identified have been fully priced in.

Five additional funds reduced their Northrop Grumman positions to varying degrees. The breadth of selling across different fund types — including both passive managers and active hedge funds — suggests multiple factors are at play, from profit-taking after a strong run to concerns about program execution risks on the B-21 and Sentinel ICBM programs.

Notable Moves

The standout feature of this filing period is the three new positions. Having Renaissance, Bridgewater, and Baker Bros all initiate fresh NOC positions simultaneously is rare. New positions represent a higher conviction signal than incremental increases to existing holdings — these funds evaluated thousands of potential investments and chose to add Northrop Grumman to their portfolios.

Renaissance's $65.8 million new position is the largest of the three and carries particular weight given the fund's track record. Renaissance Technologies has generated annualized returns exceeding 60% in its Medallion Fund over multiple decades, making it arguably the most successful investment operation in history. Their algorithms identifying NOC as a new opportunity should not be dismissed lightly.

Canyon's complete exit provides the bearish counterpoint. Canyon Capital manages significant assets and doesn't exit positions casually. Their complete liquidation suggests either profit targets were reached or fundamental concerns emerged about Northrop's ability to execute on its massive backlog without margin compression.

What This Signals

Northrop Grumman's institutional picture is one of transition. The balanced 6-6-6 split masks a rotation occurring beneath the surface: older, more established positions are being trimmed or exited, while new money — particularly from quantitative and macro funds — is flowing in.

This rotation pattern often appears at inflection points. The funds that rode NOC's rally over the past two years are taking profits, while fresh capital from funds with different analytical frameworks sees opportunity at current levels. Whether this marks the beginning of a new leg higher or simply the rotation of one set of holders to another depends on Northrop's execution in the coming quarters.

The B-21 Raider program remains the key catalyst. As the bomber enters low-rate initial production, Northrop faces the classic defense contractor challenge: converting engineering and development work into profitable production revenue. The program's complexity — it's the most advanced aircraft ever built — creates both enormous opportunity and meaningful execution risk.

The nuclear modernization program, specifically the Sentinel ICBM replacement, provides another multi-decade revenue stream. However, this program has already faced cost overruns and schedule delays, which may be contributing to some institutional caution.

For individual investors, the three new positions from Renaissance, Bridgewater, and Baker Bros are the most actionable signal. These aren't incremental additions — they represent fresh analytical conclusions that NOC offers value at current prices. Balanced against the selling pressure, a watchful approach with a bias toward accumulation on weakness appears to match the institutional consensus.

Track NOC with Freenance Smart Money

Track NOC and 77,111 other institutional positions across 35 hedge funds with $21.4 trillion in combined AUM. See real-time buying and selling activity at app.freenance.io/smart-money/ticker/NOC.

Related Articles

• Who Is Buying NVIDIA? Hedge Fund Activity in 2026
• Who Is Buying Apple? Hedge Fund Activity in 2026
• Who Is Buying Tesla? Hedge Fund Activity in 2026

FAQ

What does a perfectly balanced 6-6-6 institutional split actually mean?

The headline split looks neutral, but the composition matters more than the count. Three brand-new positions versus mostly incremental trims indicates a quiet rotation — older holders taking profits while fresh capital with different analytical frameworks builds positions, a pattern often visible around inflection points.

Why is the B-21 Raider program so central to NOC's institutional thesis?

The B-21 is moving from engineering and development into low-rate initial production, which historically determines whether a defense program becomes a margin-positive franchise or a cost overrun. Funds buying are underwriting smooth execution, while sellers may be pricing in the historical pattern of margin compression during early production ramps.

How meaningful is Renaissance Technologies' new $65.8 million position?

Renaissance's algorithmic framework is among the most successful in market history, and a new entry of that size implies multiple model signals converged favorably. It's not a directional forecast, but it does indicate that statistical edges on price action, volatility, and underlying data look attractive at current levels.

What drove Canyon Capital's complete exit?

Canyon focuses on event-driven and distressed setups, so a full liquidation typically signals that the original catalyst either played out or was invalidated. After a strong multi-year run in defense, that may simply mean the asymmetric setup they originally identified has been priced in rather than a negative fundamental call on Northrop.

How does the Sentinel ICBM program factor into the risk picture?

Sentinel provides a multi-decade revenue stream but has already faced cost overruns and schedule delays, which likely contributes to institutional caution among sellers. How Northrop manages program costs and renegotiations on Sentinel will be a key variable for whether buyer conviction or seller skepticism proves more accurate.